Upon completion of this activity, participants should be able to assess the current use of FDA-approved biologic agents for the treatment of psoriatic arthritis in your practice and identify opportunities to better educate patients about drug efficacy and safety to improve overall adherence.
Upon completion of this activity, participants should be able to assess the most common clinical examination and laboratory findings in patients presenting with possible psoriatic arthritis (PsA) and identify the specific characteristics of PsA that differentiate the condition from other common rheumatic diseases.
This course consists of a series of videos from passionate experts presented at the 2019 12th Annual RNS Conference in Orlando, Florida. The theme for this conference was “Rheum For You,” where together, attendees learned the most up-to-date discoveries of autoimmune diseases, the latest in treatment guidelines, and effective clinical skills to increase their practice’s efficiency.
Course Summary This issue of Rheumatology Nurse Practice will review how telemedicine has evolved in the last decade; how this communication and healthcare delivery modality […]
What does a national survey of rheumatologists and dermatologists tell us about psoriatic arthritis (PsA) care, and how can we improve? In 2018, a steering […]
This issue of Rheumatology Nurse Practice will explore the growing base of knowledge regarding the pathophysiology of RA and how new agents being developed are targeting new pathways in new ways. It will also examine the growing role of biosimilars as they begin to be introduced more regularly into clinical care.
The Rheumatology Nurses Society and Haymarket Medical Education present: Immunotherapy-Induced Rheumatic Diseases: Managing the Intersection of Rheumatology and Oncology Instructions To obtain credit, a score […]
In this issue of Rheumatology Nurse Practice, we explore the options available to measure and track disease activity levels in patients with psoriatic arthritis and offer guidance on how these can be smoothly incorporated into routine clinical practice.
In this issue of Rheumatology Nurse Practice, we’ll follow a hypothetical patient from the moment they leave the rheumatology office with a DMARD prescription, tracing their steps to their insurance company, their local pharmacy (or specialty pharmacy), and their home.